- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05803226
Slow Art Plus: A Single Session Art Gallery-based Intervention for Mental Health Promotion (SAP)
April 6, 2023 updated by: Andy Hau Yan Ho, PhD, EdD, Nanyang Technological University
Slow Art Plus: Developing and Piloting a Single Session Art Gallery-based Intervention for Mental Health Promotion Via a Mixed Method Waitlist Randomized Control Trial (RCT)
Utilizing a Participatory Action Research (PAR) paradigm, this 12-month study will adopt a mixed method Waitlist Randomized Control Trial (RCT) with a built-in acceptability and feasibility study to test the efficacy of Slow Art Plus in reducing stress and empowering self-care among 200 participants.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
The specific objectives are in four-folds: 1) To develop a standardized 90-minute single-session Slow Art Plus programme that integrates: (a) slow looking; (b) mindfulness meditation; (c) self-compassion activities; (d) reflective-creative expressions; and (e) dyadic sharing, to form a holistic mental health promotion intervention; 2) To assess the effectiveness of Slow Art Plus for reducing participants' perceived stress (primary outcomes); 3) To assess the effectiveness of Slow Art Plus for enhancing participants' self-awareness, self-care capacity, psychological resilience, and quality of life (secondary outcomes); and 4) To assess the feasibility and acceptability of the standardized Slow Art Plus protocol for large scale implementation in Singapore and greater Asia.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 637332
- Nanyang Technological University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- individuals who can communicate in English and provide informed consent.
Exclusion Criteria:
- individuals who are suffering from depression or other major mental illness.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
The first 10-minute of Slow Art Plus involves a brief psychoeducation on slow looking, mindfulness, and self-compassion practices.
This is followed by a 10-minute participants self-introduction and sharing of one act of self-kindness; a 10-minute facilitator led mindfulness meditation on affectionate breathing to foster greater somatic and emotional clarity for slow-looking.
This is followed by a set of 30-minute slow looking activity with 1 selected art-piece, including: (a) creating an Artwork Title with one sentence description, (b) imaging music that resonates with the viewers' emotional response to artwork, and (c) sketching a Response Art that facilitates a dialogue between the viewer and the art piece for perspective widening.
A 10-minute dyadic sharing follows with a 5-minute large group sharing of joint collective experience.
Artwork reveal and sharing of its self-care implications is offered.
Finally, a closure self-compassion activity of Supportive Healing Touch.
|
Slow Art Plus involved a full 90-minute engagement, one that is built upon the existing Slow Art programme with added layers of mindfulness and self-compassion practices, as well as a response art activity that fosters symbolic dialogue and an emotional aesthetic experience between participants and the selected artwork.
|
No Intervention: Control
Wait-list Control Arm who will receive the Slow Art Plus after the Experimental Arm completes the Intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Stress Scale (PSS)
Time Frame: Pre-Intervention
|
The PSS comprises 10-items rated on a 5-point Likert scale and clustered into 2 subscales of perceived helplessness (e.g., "In the past couple of days, how often have you felt nervous and stressed today"), and perceived self-efficacy (e.g., In the past couple of days, how often have you felt that things were going your way").
The PSS possesses strong internal validity, reliability, and cross-cultural applicability.
|
Pre-Intervention
|
Perceived Stress Scale (PSS)
Time Frame: Immediate Post Intervention
|
The PSS comprises 10-items rated on a 5-point Likert scale and clustered into 2 subscales of perceived helplessness (e.g., "In the past couple of days, how often have you felt nervous and stressed today"), and perceived self-efficacy (e.g., In the past couple of days, how often have you felt that things were going your way").
The PSS possesses strong internal validity, reliability, and cross-cultural applicability.
|
Immediate Post Intervention
|
Perceived Stress Scale (PSS)
Time Frame: 1-Day Follow-UP
|
The PSS comprises 10-items rated on a 5-point Likert scale and clustered into 2 subscales of perceived helplessness (e.g., "In the past couple of days, how often have you felt nervous and stressed today"), and perceived self-efficacy (e.g., In the past couple of days, how often have you felt that things were going your way").
The PSS possesses strong internal validity, reliability, and cross-cultural applicability.
|
1-Day Follow-UP
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Five Facet Mindfulness Questionnaire Short Form (SF-FFMQ)
Time Frame: Pre-Intervention
|
The SF-FFMQ comprises 20 items clustered into 5 subscales: (i) observe, (ii) describe, (iii) act with awareness, (iv) non-judging of inner experience, and (v) non-reactivity to inner experience.
Higher scores indicating higher mindfulness capacity.
|
Pre-Intervention
|
Five Facet Mindfulness Questionnaire Short Form (SF-FFMQ)
Time Frame: Immediate Post Intervention
|
The SF-FFMQ comprises 20 items clustered into 5 subscales: (i) observe, (ii) describe, (iii) act with awareness, (iv) non-judging of inner experience, and (v) non-reactivity to inner experience.
Higher scores indicating higher mindfulness capacity.
|
Immediate Post Intervention
|
Five Facet Mindfulness Questionnaire Short Form (SF-FFMQ)
Time Frame: 1-Day Follow-Up
|
The SF-FFMQ comprises 20 items clustered into 5 subscales: (i) observe, (ii) describe, (iii) act with awareness, (iv) non-judging of inner experience, and (v) non-reactivity to inner experience.
Higher scores indicating higher mindfulness capacity.
|
1-Day Follow-Up
|
Self-Compassion Scale - Short Form (SCS-SF)
Time Frame: Pre-Intervention
|
The SCS-SF comprises 12 items clustered into 6 subscales: (i) self-kindness, (ii) common humanity, (iii) mindfulness, (iv) self-judgement, (v) isolation, and (iv) over-identification.
Higher scores indicating higher self-compassion capacity.
|
Pre-Intervention
|
Self-Compassion Scale - Short Form (SCS-SF)
Time Frame: Immediate Post Intervention
|
The SCS-SF comprises 12 items clustered into 6 subscales: (i) self-kindness, (ii) common humanity, (iii) mindfulness, (iv) self-judgement, (v) isolation, and (iv) over-identification.
Higher scores indicating higher self-compassion capacity.
|
Immediate Post Intervention
|
Self-Compassion Scale - Short Form (SCS-SF)
Time Frame: 1-Day Follow-Up
|
The SCS-SF comprises 12 items clustered into 6 subscales: (i) self-kindness, (ii) common humanity, (iii) mindfulness, (iv) self-judgement, (v) isolation, and (iv) over-identification.
Higher scores indicating higher self-compassion capacity.
|
1-Day Follow-Up
|
Ego-Resilience Scale-11 (ER-11)
Time Frame: Pre-Intervention
|
The ER-11 comprises 11-items clustered into 3 subscales: (i) active engagement with the world, (ii) repertoire of problem-solving strategies, and (iii) integrated performance under stress.
Higher scores indicating higher ego-resilience.
|
Pre-Intervention
|
Ego-Resilience Scale-11 (ER-11)
Time Frame: Immediate Post Intervention
|
The ER-11 comprises 11-items clustered into 3 subscales: (i) active engagement with the world, (ii) repertoire of problem-solving strategies, and (iii) integrated performance under stress.
Higher scores indicating higher ego-resilience.
|
Immediate Post Intervention
|
Ego-Resilience Scale-11 (ER-11)
Time Frame: 1-Day Follow-Up
|
The ER-11 comprises 11-items clustered into 3 subscales: (i) active engagement with the world, (ii) repertoire of problem-solving strategies, and (iii) integrated performance under stress.
Higher scores indicating higher ego-resilience.
|
1-Day Follow-Up
|
Single-Item Quality of Life Scale (SI-QOLS)
Time Frame: Pre-Intervention
|
1 item measures quality of life.
Higher scores indicating higher QOL.
|
Pre-Intervention
|
Single-Item Quality of Life Scale (SI-QOLS)
Time Frame: Immediate Post Intervention
|
1 item measures quality of life.
Higher scores indicating higher QOL.
|
Immediate Post Intervention
|
Single-Item Quality of Life Scale (SI-QOLS)
Time Frame: 1-Day Follow-Up
|
1 item measures quality of life.
|
1-Day Follow-Up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 14, 2022
Primary Completion (Anticipated)
December 31, 2023
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
March 22, 2023
First Submitted That Met QC Criteria
April 6, 2023
First Posted (Actual)
April 7, 2023
Study Record Updates
Last Update Posted (Actual)
April 7, 2023
Last Update Submitted That Met QC Criteria
April 6, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 04IDP001152C430
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Compassion
-
Fundación Saldarriaga ConchaPontificia Universidad Javeriana; Ministerio de Ciencia, Tecnología e InnovaciónNot yet recruitingResilience, Compassion
-
University of CoimbraFundação para a Ciência e a TecnologiaActive, not recruiting
-
Firat UniversityRecruitingSelf-Compassion TrainingTurkey
-
Hospital Israelita Albert EinsteinCompletedAttention | Self-compassionBrazil
-
University of Texas at AustinCompleted
-
Beijing Normal UniversityCompleted
-
Mackay Medical CollegeCompletedCompassion | Educational Problems | CompetenceTaiwan
-
Brigham Young UniversityTerminatedCompassion | Guilt | Self-Criticism | ShameUnited States
-
Universitat Jaume IEuropean Social Fund; Generalitat ValencianaCompletedCompassion | Mental Health Wellness 1Spain
-
Boston University Charles River CampusCompleted
Clinical Trials on Slow Art Plus
-
Tang-Du HospitalZhejiang University; Chipscreen Biosciences, Ltd.; First Affiliated Hospital...UnknownChronic HIV InfectionsChina
-
Old Dominion UniversityCompletedAnxiety | Visceral Pain | Gastrointestinal System--AbnormalitiesUnited States
-
Dr. Tarit SahaCompleted
-
National Hepatology & Tropical Medicine Research...Recruiting
-
Calvary Hospital, Bronx, NYCompletedPVD | Arterial UlcersUnited States
-
Laboratoires NEGMAUnknown
-
University of AarhusInnovation Fund DenmarkRecruitingAthletic PerformanceDenmark
-
Children's Hospital Medical Center, CincinnatiVirginia Commonwealth UniversityCompletedPreterm InfantUnited States
-
Shanghai Zhongshan HospitalUnknownNeoplasms | Lymphoma | Inflammation | Cancer | Infection | Sarcoid | Mass LesionChina
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH); Oregon Clinical...CompletedPost-Traumatic Stress DisordersUnited States